WELCOME TO THE MANUFACTURING REPORT
Sangram Vajre, Co-Founder & Chief Evangelist at Terminus is also an author and host of the podcast FlipmyFunnel. He is one of the leading minds in B2B marketin...
DECK 7 | January 13, 2020
DECK 7 is proud to present an exciting interview with the Co-Founder & Chief Evangelist at Terminus, Sangram Vajre. He is an author, keynote speaker, 3x CMO, host of the daily #FlipMyFunnel podcast, entrepreneur and category maker. Sangram has been a driving force behind the success of Terminus and building the ABM subcategory of marketing technology. Before co-founding Terminus, Sangram was Head of Marketing at Pardot through its acquisition by ExactTarget and then Salesforce. A contributin...
ELEMENTUM 3D | January 13, 2020
Additive manufacturing research and development company Elementum 3D has received investment from Sumitomo Corporation of Americas through its Series A funding round. The undisclosed amount has been given to Elementum in order to support its endeavours in the development of advanced metal, composites and ceramic materials for 3D printing. It represents SCOA’s fourth investment in the additive manufacturing market, after backing aerospace supplier Sintavia, manufacturer AREVO, and service b...
Manufacturing Global | January 13, 2020
Shannon Murphy, Assistant Head of Risk Underwriting and manufacturing specialist at Euler Hermes, examines the last 12 months and explains where the risks lie for the sector in the year ahead. Manufacturers around the world have had a challenging year in 2019. The impact of the ongoing trade dispute between the US and China and uncertainty surrounding the UK’s withdrawal from the EU have both contributed to the slowing of the global economy, which will have given the sector’s leaders...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE